NUVL
Price
$81.41
Change
-$0.67 (-0.82%)
Updated
Jul 25 closing price
Capitalization
5.85B
12 days until earnings call
RVMD
Price
$37.91
Change
+$0.68 (+1.83%)
Updated
Jul 25 closing price
Capitalization
7.06B
11 days until earnings call
Interact to see
Advertisement

NUVL vs RVMD

Header iconNUVL vs RVMD Comparison
Open Charts NUVL vs RVMDBanner chart's image
Nuvalent
Price$81.41
Change-$0.67 (-0.82%)
Volume$1.35M
Capitalization5.85B
Revolution Medicines
Price$37.91
Change+$0.68 (+1.83%)
Volume$1.23M
Capitalization7.06B
NUVL vs RVMD Comparison Chart in %
Loading...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVL vs. RVMD commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a Hold and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (NUVL: $81.41 vs. RVMD: $37.90)
Brand notoriety: NUVL and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 248% vs. RVMD: 53%
Market capitalization -- NUVL: $5.85B vs. RVMD: $7.06B
NUVL [@Biotechnology] is valued at $5.85B. RVMD’s [@Biotechnology] market capitalization is $7.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • NUVL’s TA Score: 4 bullish, 3 bearish.
  • RVMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than RVMD.

Price Growth

NUVL (@Biotechnology) experienced а -2.39% price change this week, while RVMD (@Biotechnology) price change was -1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

NUVL is expected to report earnings on Nov 06, 2025.

RVMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.06B) has a higher market cap than NUVL($5.85B). NUVL YTD gains are higher at: 3.998 vs. RVMD (-13.340). NUVL has higher annual earnings (EBITDA): -322.59M vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. NUVL (1.07B). NUVL (0) and RVMD (0) have equivalent revenues.
NUVLRVMDNUVL / RVMD
Capitalization5.85B7.06B83%
EBITDA-322.59M-776.65M42%
Gain YTD3.998-13.340-30%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.07B2.1B51%
Total DebtN/A134M-
TECHNICAL ANALYSIS
Technical Analysis
NUVLRVMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYSCX12.55N/A
N/A
Macquarie Smid Cap Core Fund Class C
TRZBX209.70N/A
N/A
T. Rowe Price Blue Chip Growth Z
SASVX6.46N/A
N/A
Virtus Ceredex Small-Cap Value Eq A
MAEGX15.43N/A
N/A
BlackRock Unconstrained Equity Instl
MGTSX40.99N/A
N/A
Morgan Stanley Inst Global Opp R6

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.82%
CGON - NUVL
55%
Loosely correlated
-0.15%
ABCZF - NUVL
51%
Loosely correlated
N/A
CRNX - NUVL
51%
Loosely correlated
+1.91%
KYMR - NUVL
50%
Loosely correlated
-0.13%
ROIV - NUVL
50%
Loosely correlated
+1.49%
More